Vitamin markets: Calm as Q1 2025 is mostly contracted
Vitamin E remains stable at a high level. With no change expected in the short-term, as supply and demand are pretty balanced. Suppliers don’t want to lower prices and buyers are not yet in a hurry to buy new material. Learn more in this week’s feed additives snapshot (week 51).
Although this week the price has been stable so far, vitamin A has been going down in price lately as new capacity from China will be introduced most likely early 2025 and there has been no additional demand lately.
Vitamin D3 still remains firm and suppliers are very keen to raise the price further or at least maintain the current level. Availability remains tight in most regions.
Vitamin B3 is stable and so is vitamin B5. Vitamin B1 and B6 remain stable to firmer. Folic acid prices have increased significantly and that has triggered buying for Q1 at least. The market has become more calm now and the number of transactions went down. Prices are still elevated though.
In partnership with Feed Additive Prices
Vitamin E 50%
At the moment the vitamin E market seems balanced, at a high price level. Suppliers are very keen to maintain at least the current price level and act accordingly. And buyers are conservative and are contracted for a portion of Q1 and wait and see. No short-term changes are expected to these dynamics. It is said that additional capacity will come on the market in 2025, but that remains to be seen. Right now the market is relatively quiet and contracted for a good portion of Q1.
Vitamin A 1000
After some price decline in the previous weeks, it seems prices are more stable this week. There is a price spread in some regions between Chinese and Western material, with Chinese being slightly lower. Most manufacturers try to keep prices stable or up, at this relatively high level. Availability seems to be slightly better plus the arrival of new capacity in the market from China has been fuelling a weaker market price. Buyers have already secured a decent part of their Q1 needs.
Vitamin D3 500
The general tone is still tight in terms of availability and prices remain high and seem to stick. No nearby change is expected, although some buyers have to return to the market in late Q4/early q1 in order to secure more volume. These buyers had a wait-and-see attitude before but realise now that a short-term price reduction is not realistic. Q4 is contracted and a decent portion of Q1 as well.
Vitamin B2 80%
Prices in Europe remain firmer compared to earlier this year, as there are no Chinese sources available, and Western sources indicate that they have limited material available. Prices FOB China and in the USA remain relatively stable and no nearby changes are expected. Q4 has been contracted and a good portion of Q1 as well.
D-Calpan
Relatively static market. Prices remain stable at a relatively low level and that goes for all regions. As there is an oversupply situation for this product, no signs of nearby change are expected. A good portion of Q1 is contracted.
Vitamin B3
No changes are seen in the market compared to previous weeks. There is still an ongoing desire by most manufacturers to increase prices and the raw material situation is said to be still tight in several cases. Yet, the market is not reacting to that in terms of booking more ahead or paying higher prices right now. It is still relatively quiet. Buyers had secured their Q4 and partially Q1 needs some time ago and after that, the market has gone quiet.
Biotin
No signs of any sort of change in the biotin market are seen or reported. Very static market at the moment. New additional production capacity in China has recently been announced for 2025. A good portion of Q1 is contracted.
Vitamin C 35% mono
Most suppliers continue to insist on firmer prices and/or are not even offering at all. In general, prices are stable and the number of transactions is very limited. Overall, the market is very quiet. A decent portion of Q1 has been contracted.
